Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib

Clinical trial NCT02348957 · COMPLETED

Trial details

NCT number: NCT02348957
Sponsor: Onco Medical Consult GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Myeloid Leukemia, Chronic, Chronic-Phase

Start date: 2014-10-01
Primary completion: 2019-03-01
Enrollment: 223

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.